Dare Bioscience, Inc. DARE 深 沪
已收盘 05-08 16:00:00 美东时间
2.75
-0.160
-5.50%
华盛通- 最 高2.94
- 今 开2.94
- 成交量 55.86万股
- 最 低 2.65
- 昨 收 2.91
- 总市值 4003.86万
- 52周最高 9.19
- 市盈率 静 --
- 换手率 3.84%
- 52周最低 1.27
- 委 比 86.48%
- 总股本 1455.95万
- 历史最高 76.44
- 量 比 0.31
- 振 幅 9.97%
- 历史最低 1.27
- 每 手 1
- 风险率 0.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Psyence Biomedical (NASDAQ:PBM) shares increased by 63.4% to $9.59 dur...
04-17 05:05
Dare Bioscience Q4 EPS $(0.02) Beats $(0.43) Estimate, Sales $1.024M Beat $375.750K Estimate
Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.43) by 95.37 percent. This is a 96.92 percent increase over losses of $(0.65) per share from
03-27 04:05
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
Daré Bioscience Gets ~$2M Funding From National Institutes Of Health's Division For Its Intravaginal Ring DARE-PTB1 For Prevention Of Preterm Birth
Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced receipt of a revised
03-16 20:08
Daré Bioscience Announces FDA Clears Its Investigational New Drug Application For DARE-HPV To Initiate Planned Phase 2 Clinical Study For Papillomavirus Infection Treatment
Daré Bioscience, Inc. (NASDAQ:DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that the U.S. Food and
02-23 21:04
Daré Bioscience Launches First Evidence-Backed Topical Sildenafil Cream For Women
Developed and evaluated specifically for women, DARE to PLAY™ Sildenafil Cream is a first-of-its-kind female arousal cream, a non-hormonal topical cream shown in clinical studies to increase genital blood flow in
2025-12-10 21:08
美股大行评级 | 最高500美元！MongoDB获18家大行紧急上调目标价；巴克莱下调理想汽车目标价至18美元
今日重点评级关注：B. Riley证券：维持Seabridge Gold"买入"评级，目标价从50美元升至65美元；HC Wainwright & Co.：维持TRX Gold"买入"评级，目标价从1.2美元升至1.4美元
2025-12-03 09:58
HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $12 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $12 price target.
2025-12-02 19:57
Daré Bioscience Regains Full Rights To Ovaprene As Bayer Terminates License Agreement
Daré Bioscience, Inc. (NASDAQ:DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that all rights to
2025-12-01 21:10
Daré Bioscience Receives About $3.6M Payment Under Existing Grant Agreement With Gates Foundation
Daré Bioscience, Inc. (NASDAQ:DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that it has received
2025-11-24 21:04
